Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech IPO
Biotech
I-Mab unveils new name, strategy, asset and Hong Kong IPO plans
Less than two years after laying out plans to divest its China operations, I-Mab Biopharma is re-staking its claim in the Asia-Pacific region.
Andrea Park
Oct 17, 2025 10:45am
Inflammation biotech Evommune eyes IPO to fund dermatitis trials
Oct 10, 2025 6:35am
MapLight illuminates $262M IPO plans to fund Cobenfy competitor
Oct 7, 2025 6:30am
Big Pharma-backed MapLight plots IPO
Sep 22, 2025 1:57pm
LB Pharma upsizes IPO in 1st biotech listing since February
Sep 11, 2025 4:09am
LB Pharmaceuticals eyes $228M in IPO cash
Sep 8, 2025 3:16pm
